Natural Investments LLC Grows Stake in Colgate-Palmolive Company $CL

Natural Investments LLC lifted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 7.5% in the second quarter, Holdings Channel reports. The firm owned 5,029 shares of the company’s stock after buying an additional 353 shares during the period. Natural Investments LLC’s holdings in Colgate-Palmolive were worth $457,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Westend Capital Management LLC increased its stake in shares of Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 140 shares in the last quarter. Cornerstone Planning Group LLC increased its stake in shares of Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after purchasing an additional 287 shares in the last quarter. Saudi Central Bank purchased a new stake in shares of Colgate-Palmolive during the first quarter worth about $29,000. Ransom Advisory Ltd purchased a new stake in shares of Colgate-Palmolive during the first quarter worth about $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Colgate-Palmolive during the 1st quarter valued at about $37,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $77.99 on Friday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The firm has a market capitalization of $63.03 billion, a price-to-earnings ratio of 21.91, a PEG ratio of 4.29 and a beta of 0.34. The company’s 50-day moving average is $82.56 and its two-hundred day moving average is $87.88. Colgate-Palmolive Company has a 1-year low of $77.09 and a 1-year high of $102.61.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive’s revenue was up 1.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.91 EPS. Analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is currently 58.43%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CL. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday. Piper Sandler began coverage on shares of Colgate-Palmolive in a research note on Friday, October 3rd. They set a “neutral” rating and a $84.00 price objective for the company. UBS Group dropped their price objective on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating for the company in a research note on Wednesday. Citigroup dropped their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a research note on Monday, August 4th. Finally, Bank of America dropped their price objective on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $92.21.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.